Finding the right dose of EXL-111 for healthy volunteers
Treatments studied
Part of Immune system & allergy clinical trials.
This trial tests a new drug called EXL-111 in healthy people to find the safest and best dose for future studies. It may help people with allergies if the drug proves effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old
- You weigh between 99 and 264 pounds with a body mass index between 18 and 32
- Your blood level of an antibody related to allergies (called IgE) is in a specific range (30 to 300 IU/mL)
- You do not smoke or use tobacco, and haven't for the past 2 months (very light use may be okay)
- You are willing to follow study rules and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called S-1117 in healthy volunteers to see how safe it is and how it works in the body. It is a first-in-human trial that helps researchers learn about the medication before testing it in people with a condition.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
This trial tests if inhaled epinephrine can safely treat moderate to severe allergic reactions (grade 2 or higher) that can happen during allergy skin tests, oral food or drug challenges, or allergy shots. It is for people who have had such reactions in the past or are at risk and are planning to undergo one of these procedures.
This study tests if omalizumab (Xolair), an injectable medicine that blocks allergy antibodies, can help people with food allergies tolerate small amounts of their trigger foods. It's for people with high total IgE levels who were not eligible for a related study.
This study compares two versions of an experimental drug called 611 to see how they work in the body. It's for healthy volunteers to help find the best formulation for future treatments.
This trial is testing a new drug called HX15001 in healthy adults to see how safe it is and how the body processes it. It may help researchers decide if the drug can be tested in people with a specific condition in the future.
Hear when a new Allergic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.